October 10, 2017
9 am to 10 am EDT

Sponsored by

Webinar Description:

Utilizing our proprietary MonoRabTM technology, GenScript provides custom rabbit (monoclonal antibodies) mAbs service to meet your specific requirements in antibody drug development and in vitro diagnostics. With the combination of hybridoma technology and early-stage antibody sequencing capability, we demonstrated our capability of developing rabbit mAbs against challenging targets, such as nanobodies, antibodies, membrane receptors, small molecule compounds, and antibody drug targets. GenScript's 13-year expertise can facilitate you in developing high quality rabbit mAbs to meet your stringent requirements in downstream applications.

Speaker:

Liusong Yin, PhD

Head of Antibody Department

GenScript

Dr. Yin received his Ph.D. from University of Massachusetts Medical School, specialized in antigen presentation and CD4+ T cell epitope selection. He then joined Pfizer as a postdoctoral fellow specialized in immunogenicity of therapeutic biologics. Dr. Yin has extensive experience in Ab drug discovery, especially in DNA immunization, high throughput FACS screening, ELISA kit development and anti-idiotype antibody development for Ab drug PD/PK studies.